Key Events This Week
1 June: Sharp quarterly decline reported; stock drops 4.32%
4 June: Heavy volume selling amid operational concerns; stock falls 4.15%
5 June: Continued weakness with minor decline of 0.25%
Jun 29, 11:43 AM
BSE+NSE Vol: 17
1 June: Sharp quarterly decline reported; stock drops 4.32%
4 June: Heavy volume selling amid operational concerns; stock falls 4.15%
5 June: Continued weakness with minor decline of 0.25%
Centenial Surgical Suture Ltd's latest financial results for the quarter ended March 2026 reveal significant operational challenges and a concerning trend in profitability. The company reported net sales of ₹12.58 crores, reflecting a year-on-year decline of 5.48%, which indicates a struggle to maintain revenue momentum. This performance is further compounded by a net profit loss of ₹2.31 crores, marking a drastic year-on-year decrease of 95.76%. The operating profit margin has compressed to 7.39%, down from 15.55% in the same quarter last year, highlighting severe operational stress and inadequate cost management. Additionally, interest costs surged dramatically by 531% quarter-on-quarter to ₹2.21 crores, which has significantly impacted the company's financial health, consuming the entirety of its operating profit and pushing it into a pre-tax loss. Overall, the financial data indicates that Centenial ...
Read full news article
Centenial Surgical Suture Ltd., a micro-cap surgical sutures manufacturer with a market capitalisation of ₹33.00 crores, reported a concerning quarter ended March 2026, with net losses widening to ₹2.31 crores compared to a loss of ₹1.18 crores in the year-ago period. The quarter marked the company's weakest operational performance in recent years, with revenue declining 15.34% sequentially to ₹12.58 crores whilst operating margins compressed to just 7.39%—the lowest in the trailing twelve-month period.
Read full news article
Centenial Surgical Suture Ltd has reported a significant downturn in its financial performance for the quarter ended March 2026, marking a stark reversal from its previously positive trajectory. The company’s key metrics, including net sales, profit after tax, and operating margins, have all deteriorated sharply, signalling mounting challenges in the healthcare services sector for this micro-cap player.
Read full news article
Centenial Surgical Suture Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Centenial Surgical Suture Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Centenial Surgical Suture Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Centenial Surgical Suture Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news articleIntimation under Reg 30 SEBI (LODR) Regulations 2015 - Retirement of Senior Management Personnel (SMP)
PFA
PFA
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available